International Clinical Trial: Study on a Pan-cancer Multidimensional Immune Efficacy Prediction and Early Warning Model Integrating the "Treating Different Diseases with the Same Method" Theory of Traditional Chinese Medicine and Artificial Intelligence

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132990) titled 'Study on a Pan-cancer Multidimensional Immune Efficacy Prediction and Early Warning Model Integrating the "Treating Different Diseases with the Same Method" Theory of Traditional Chinese Medicine and Artificial Intelligence' on Sept. 20.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Sichuan Cancer Hospital

Condition: Gastric cancer, lung cancer, breast cancer, esophageal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Observation group of combined traditional Chinese and Western medicine immunotherapy:2743;

Co...